Veterinary pharmaceuticals

Producing stable drug formulations is one of the main challenges faced by pharmaceutical formulators. At Croda, we believe in developing the highest quality and purest grades of excipients to help you formulate seamlessly, minimise failed batches and drive your products to market. We have created our most exclusive range, Super Refined excipients, to ensure that your formulations are stable, effective, and consistent.

Controlled release oral dosage forms for companion animals represent a challenge because of both gastrointestinal physiology and eating habits. We have developed in-house capabilities and expertise in recent years to gain understanding of effects of high purity excipients and SEDDS and SMEDDs formulations on oral absorption in vitro.

Topical spot-on formulations have become increasingly popular as a convenient dosing options for companion animals. Our Super Refined range can not only aid with solubilising and stabilising sparingly soluble actives but can also improve delivery of the active through the skin using permeation enhancers. These benefits ultimately add value for the next generation of spot-on formulations.

In combination with penetration studies, we can develop tailored and effective pour-on formulations to help improve both the performance of new drugs and maximising return from existing products. 

Developing a drug to be administered via the ophthalmic, auricular and nasal routes requires focus on key factors such as drug stabilisation and endotoxin levels. High purity excipients are suitable for stabilising, solubilising and delivering APIs through the ophthalmic, auricular and nasal delivery routes and our portfolio includes:
• Solubilisers
• Emulsifiers
• Stability enhancers